Construction and validation of a predictive model for intracardiac thrombus risk in patients with dilated

Xuetao Zhu1, Jun Li1, Yi Jiang1

  • 1Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui, 230022, P.R. China.

PubMed

Insights

This study developed a predictive model for intracardiac thrombus (ICT) in dilated cardiomyopathy (DCM) patients. The XGBoost model demonstrated high accuracy in identifying patients at risk of ICT, aiding clinical decision-making.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Predictive Analytics

Background:

  • Systemic embolic events are a severe complication of dilated cardiomyopathy (DCM).
  • Intracardiac thrombus (ICT) is a primary source of these embolic events.
  • Accurate risk prediction for ICT in DCM patients is crucial for preventing catastrophic outcomes.

Purpose of the Study:

  • To develop and validate a predictive model for identifying the risk of intracardiac thrombus (ICT) in patients with dilated cardiomyopathy (DCM).
  • To compare the performance of different machine learning classifiers for ICT risk prediction.

Main Methods:

  • Utilized data from 632 DCM patients, including clinical, vital sign, comorbidity, and biochemical data.
  • Employed transthoracic echocardiography for ICT identification.
  • Applied Least Absolute Shrinkage and Selection Operator (LASSO) regression for variable selection.
  • Constructed and evaluated four models: Logistic Regression, Support Vector Machine (SVM), Random Forest, and eXtreme Gradient Boosting (XGBoost).

Main Results:

  • Out of 632 patients, 13.92% had ICT.
  • The XGBoost model achieved the highest Area Under the Curve (AUC) of 0.947 (95% CI: 0.924-0.969), outperforming other models.
  • Key predictors identified by the XGBoost model included D-dimer levels, age, and atrial fibrillation.

Conclusions:

  • The XGBoost model demonstrates strong predictive capability for ICT risk in DCM patients.
  • This model can serve as a valuable tool for clinicians to identify high-risk individuals.
  • Early identification of ICT risk can potentially mitigate embolic event complications.
Abstract